Navigation Links
Research highlights from ICAAC meeting
Date:9/4/2013

es the bacteria more susceptible to antibiotic treatment. Anti-AT antibodies may be a useful adjunct therapy for treatment of biofilm-forming S. aureus infections.

Michele Anderson, Univ. of Minnesota, Minneapolis, MN, United States

Slide Session 35, Paper B-306 (summary available)

C. difficile Rate Nearly Double Since 2001

The incidence of C. difficile infections in hospitals in the United States nearly doubled from 2001 to 2010.

Kelly Daniels, The Univ. of Texas at Austin, Austin, TX, United States

Slide Session 38, Paper K-327 (summary available)

Treatment Helps Prevent Recurrence of C. difficile

In patients who had previously been diagnosed with C. difficile infection and also required antibiotic treatment for other conditions, the addition of oral vancomycin to the necessary antibiotic treatment helped reduce the recurrence of C. difficile infection.

Alex Carignan, Universite de Sherbrooke, Sherbrooke, QC, Canada

Slide Session 38, Paper K-334

Dosages Equally Effective for C. difficile

There appears to be little difference in the effectiveness of low-dose versus high-dose oral vancomycin for the treatment of C. difficile infections in hospitals. Use of low-dose oral vancomycin can potentially decrease treatment costs.

Philip Chung, Albert Einstein Coll. of Med., Bronx, NY, United States

Slide Session 38, Paper K-335 (summary available)

WEDNESDAY, September 11, 2013

Anti-Infective Therapy in the 21st Century: Target the Host!

Since the discovery of sulfonamides, the goal of anti-infective therapy has been to kill the pathogen. However, recent science indicates that the host response to the pathogen profoundly influences the clinical course and outcome of infections. This symposium will review cutting edge approaches to find new ways to treat infections, modulate host response to the pathogen, a
'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
202-942-9389
American Society for Microbiology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. Frost & Sullivan: Diagnostic and Therapeutic Potential of microRNAs Stimulate Need for More Research Tools
2. Research identifies how mouth cells resist Candida infection
3. Researchers untangle genetics of drug resistant TB
4. Worlds scientists, researchers and nutrition experts convene to explore the benefits of mushrooms
5. Researchers track antibiotic-resistant strains of Salmonella from farm to fork
6. LSU research responsible for naming 15 new species of Amazonian birds
7. Researchers develop model of near-optimal genetic code
8. Researchers develop novel polymer to help oral medications reach the bloodstream
9. New ASCB Kaluza Prize recognizes graduate student research
10. Researchers develop rapid, cost-effective early detection method for organ transplant injury
11. UTHealth, Swedish researchers uncover mystery in blot clotting disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... 2015 The report "Multi-Factor Authentication (MFA) ... Application (Travel & Immigration, Government, Banking, Defense, Commercial Security, ... 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is expected ... a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ages ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
(Date:8/18/2015)... Aug. 18, 2015  Navitas today announced ... to the Submission Content Management webinar scheduled ... non-profit forum. Dedicated to the Implementation of Regulatory ... platform for industry, vendors, health authorities, consultants ... work towards a standard method of implementing ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... Piera Pasinelli, Ph.D., co-director of the Frances ... the Farber Institute for Neurosciences at Thomas Jefferson ... Research Foundation grant to identify why drug therapies ... mouse models have proven unsuccessful in human clinical ...
... the deadly Hendra virus spreads promises to save the ... CSIRO Livestock Industries, scientists working at the Australian ... a major breakthrough in better understanding how Hendra spreads ... Funded by the Australian Biosecurity CRC for ...
... Climate change will cause some of Australia,s potential weeds to ... by scientists at CSIRO,s Climate Adaptation Flagship. Weeds cost ... or lost production and cause serious damage to the environment. ... GREENHOUSE 09 conference on climate change, CSIRO researcher, Dr John ...
Cached Biology News:Jefferson researcher awarded Landenberger Foundation grant for ALS research 2Minimizing the spread of deadly Hendra virus 2Climate change may wake up 'sleeper' weeds 2
(Date:9/3/2015)... CITY, Calif. , Sept. 3, 2015 /PRNewswire/ ... today that five abstracts highlighting the performance and ... have been accepted for oral and poster presentations ... Lung Cancer,s 16th World Conference on Lung Cancer. ... Center; the University of California, Davis; the University ...
(Date:9/3/2015)... -- According to a new market research ... Flash), GC, Other Components (Autosamplers, Detectors, Fraction Collectors), by ... & Global Forecasts to 2020", published by MarketsandMarkets, The ... Billion by 2020 from USD 7.062 Billion in 2015, ... tables and 36 figures spread through 277 Pages and ...
(Date:9/2/2015)... Axovant Sciences Ltd. (NYSE:  AXON), a leading clinical-stage ... upcoming presentations at three investor conferences: , Wednesday, ... Conference in New York at the ... 2:00 PM at the BioCentury NewsMakers Conference in ... Conference Center , Thursday, September 17 at 9:30 AM ...
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... on technologies and applications. The report starts with ... estimation of markets. Technologies include array comparative genomic ...
Breaking Biology Technology:Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2
... 2011 Jennerex, Inc., a private clinical-stage biotherapeutics ... first-in-class targeted oncolytic products for cancer, today announced ... using JX-594 to treat patients with metastatic melanoma ... Therapy . "This clinical trial ...
... watch videos, store pictures, and edit all kinds of media ... digital data, that is, bits and bytes. Modern computing technology ... digital information as efficiently as possible. In a computer hard ... a thin magnetic layer, where magnetic domains pointing "up" represent ...
... Leading medical malpractice insurance company, Healthcare Providers Insurance ... its New Jersey operations.  The company has opened a ... to continue servicing the medical community in New Jersey. ... in New Jersey since 2005.   ...
Cached Biology Technology:Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma 2Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma 3Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma 4The art of magnetic writing 2Medical Malpractice Insurance Company- Healthcare Providers Insurance Exchange (HPIX) has Expanded its Presence in New Jersey, Opens New Office 2
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
... Cell Characterization Kit consists of two components ... well as four ES cell-specific antibodies required ... Stem cells have become the subject of ... therapeutic potential and because they raise several ...
Application: For use as a carrier in nucleic acid purification and precipitation. Physical form: Solution in 10 mM Tris HCl, pH 7.4, 1 mM EDTA Concentration: 9-11 mg/mL Physical Form: buffered aqu...
... as a carrier in nucleic ... form: Solution in 10 mM ... mM EDTA Preparation Note: Phenol-chloroform ... Concentration: 10 mg/mL Physical ...
Biology Products: